Sign up
CYTK

Cytokinetics Inc (NASDAQ: CYTK)

Healthcare · Biotechnology

$51.32

Last close · Nov 18, 2026 · NASDAQ USD

Set alert

The Quantellect read. Short interest is 12.92% of float with a 0.28% borrow fee. 17 active firms cover the stock as of Nov 19, 2026; 16 active firms with targets average $108.44 over 12 months. Descriptive summary of the data on this page, not a recommendation.

Relative valuationHigher multiples than peers

P/S 69.0× vs peer median 13.9×

MomentumNeutral

RSI (14) 38.2 (overbought above 70, oversold below 30) · as of Nov 18, 2026

TrendBelow both averages

$51.32 vs $62.79 and $69.59 · as of Nov 18, 2026

Short interest12.9% of float

FINRA settlement Oct 30, 2026

CYTK price chart

Price $51.32 · As of Nov 18, 2026, 8:47 PM ET

Open full chart →
Nov 18, 2026O $51.48H $52.84L $51.00C $51.32Vol 1.58M

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First dateMay 18, 2026 ET
Last dateNov 18, 2026 ET
Open$75.81
High$88.31
Low$51.00
Close$51.32
Volume262,102,039
Plotted bars129

Plotted OHLCV bars

  1. May 18, 2026 ET · Open $75.81 · High $76.55 · Low $74.64 · Close $75.18 · Volume 1,798,155
  2. May 19, 2026 ET · Open $75.65 · High $76.78 · Low $73.00 · Close $76.45 · Volume 2,399,087
  3. May 20, 2026 ET · Open $77.08 · High $79.12 · Low $76.30 · Close $78.77 · Volume 2,379,527
  4. May 21, 2026 ET · Open $78.39 · High $79.09 · Low $77.60 · Close $78.06 · Volume 1,775,261
  5. May 22, 2026 ET · Open $78.39 · High $78.92 · Low $76.58 · Close $76.94 · Volume 1,111,298
  6. May 26, 2026 ET · Open $77.01 · High $77.26 · Low $75.50 · Close $76.29 · Volume 1,652,111
  7. May 27, 2026 ET · Open $76.41 · High $77.91 · Low $75.86 · Close $77.15 · Volume 1,622,201
  8. May 28, 2026 ET · Open $77.28 · High $78.85 · Low $75.00 · Close $76.81 · Volume 1,972,009
  9. May 29, 2026 ET · Open $76.67 · High $77.11 · Low $75.66 · Close $76.76 · Volume 1,844,618
  10. Jun 1, 2026 ET · Open $76.09 · High $76.48 · Low $73.18 · Close $73.68 · Volume 1,659,897
  11. Jun 2, 2026 ET · Open $72.47 · High $73.63 · Low $70.30 · Close $70.91 · Volume 1,488,012
  12. Jun 3, 2026 ET · Open $70.65 · High $72.00 · Low $70.17 · Close $70.71 · Volume 1,595,143
  13. Jun 4, 2026 ET · Open $71.07 · High $72.76 · Low $70.72 · Close $72.29 · Volume 1,312,433
  14. Jun 5, 2026 ET · Open $72.85 · High $73.47 · Low $70.58 · Close $71.48 · Volume 1,614,067
  15. Jun 8, 2026 ET · Open $72.00 · High $72.83 · Low $67.79 · Close $67.90 · Volume 2,382,475
  16. Jun 9, 2026 ET · Open $68.60 · High $70.33 · Low $66.85 · Close $68.45 · Volume 2,492,667
  17. Jun 10, 2026 ET · Open $68.06 · High $70.29 · Low $66.63 · Close $67.07 · Volume 1,404,875
  18. Jun 11, 2026 ET · Open $67.50 · High $70.55 · Low $67.45 · Close $69.27 · Volume 1,443,394
  19. Jun 12, 2026 ET · Open $69.74 · High $71.25 · Low $69.06 · Close $70.15 · Volume 1,292,937
  20. Jun 15, 2026 ET · Open $70.15 · High $71.38 · Low $68.84 · Close $71.38 · Volume 1,012,618
  21. Jun 16, 2026 ET · Open $73.00 · High $77.00 · Low $72.15 · Close $75.21 · Volume 3,973,985
  22. Jun 17, 2026 ET · Open $75.80 · High $79.30 · Low $75.75 · Close $78.11 · Volume 3,340,445
  23. Jun 18, 2026 ET · Open $79.41 · High $80.15 · Low $77.14 · Close $78.78 · Volume 3,547,472
  24. Jun 22, 2026 ET · Open $80.00 · High $80.80 · Low $78.36 · Close $79.17 · Volume 2,888,382
  25. Jun 23, 2026 ET · Open $78.99 · High $80.40 · Low $78.27 · Close $80.01 · Volume 2,077,619
  26. Jun 24, 2026 ET · Open $80.53 · High $82.83 · Low $79.12 · Close $81.20 · Volume 2,425,736
  27. Jun 25, 2026 ET · Open $80.84 · High $82.95 · Low $80.37 · Close $80.80 · Volume 2,386,645
  28. Jun 26, 2026 ET · Open $80.80 · High $84.55 · Low $80.04 · Close $82.19 · Volume 7,164,201
  29. Jun 29, 2026 ET · Open $85.00 · High $87.35 · Low $84.51 · Close $87.26 · Volume 3,635,432
  30. Jun 30, 2026 ET · Open $87.79 · High $88.31 · Low $84.89 · Close $85.19 · Volume 2,403,866
  31. Jul 1, 2026 ET · Open $85.02 · High $85.49 · Low $83.90 · Close $85.26 · Volume 2,147,458
  32. Jul 2, 2026 ET · Open $86.09 · High $87.42 · Low $84.62 · Close $86.49 · Volume 2,030,297
  33. Jul 6, 2026 ET · Open $86.04 · High $86.88 · Low $84.45 · Close $85.57 · Volume 2,239,559
  34. Jul 7, 2026 ET · Open $86.09 · High $87.93 · Low $85.55 · Close $85.56 · Volume 2,293,475
  35. Jul 8, 2026 ET · Open $85.00 · High $85.87 · Low $82.20 · Close $84.88 · Volume 2,377,531
  36. Jul 9, 2026 ET · Open $84.48 · High $86.20 · Low $83.61 · Close $86.07 · Volume 1,691,646
  37. Jul 10, 2026 ET · Open $86.16 · High $86.45 · Low $83.59 · Close $84.87 · Volume 1,768,032
  38. Jul 13, 2026 ET · Open $83.39 · High $84.60 · Low $80.90 · Close $82.24 · Volume 1,891,495
  39. Jul 14, 2026 ET · Open $83.00 · High $83.44 · Low $80.61 · Close $81.93 · Volume 1,439,629
  40. Jul 15, 2026 ET · Open $81.03 · High $82.76 · Low $80.33 · Close $82.62 · Volume 1,334,079
  41. Jul 16, 2026 ET · Open $82.49 · High $83.71 · Low $79.81 · Close $80.36 · Volume 1,406,793
  42. Jul 17, 2026 ET · Open $78.99 · High $82.58 · Low $78.27 · Close $80.18 · Volume 1,588,488
  43. Jul 20, 2026 ET · Open $80.44 · High $81.31 · Low $78.87 · Close $79.11 · Volume 1,468,722
  44. Jul 21, 2026 ET · Open $78.97 · High $81.55 · Low $78.82 · Close $81.11 · Volume 1,215,829
  45. Jul 22, 2026 ET · Open $81.28 · High $83.83 · Low $80.61 · Close $82.19 · Volume 2,072,345
  46. Jul 23, 2026 ET · Open $80.89 · High $82.99 · Low $80.06 · Close $81.92 · Volume 1,076,211
  47. Jul 24, 2026 ET · Open $82.59 · High $82.59 · Low $80.28 · Close $80.74 · Volume 1,638,260
  48. Jul 27, 2026 ET · Open $81.51 · High $82.41 · Low $79.90 · Close $80.62 · Volume 1,835,104
  49. Jul 28, 2026 ET · Open $81.02 · High $81.02 · Low $78.98 · Close $79.45 · Volume 1,659,987
  50. Jul 29, 2026 ET · Open $79.77 · High $80.34 · Low $78.07 · Close $78.39 · Volume 1,780,885
  51. Jul 30, 2026 ET · Open $78.39 · High $80.84 · Low $77.90 · Close $80.42 · Volume 2,092,473
  52. Jul 31, 2026 ET · Open $80.32 · High $80.81 · Low $76.96 · Close $77.13 · Volume 1,579,231
  53. Aug 3, 2026 ET · Open $76.69 · High $77.17 · Low $74.89 · Close $76.45 · Volume 2,240,096
  54. Aug 4, 2026 ET · Open $77.25 · High $79.82 · Low $76.70 · Close $78.61 · Volume 2,447,492
  55. Aug 5, 2026 ET · Open $79.42 · High $80.49 · Low $77.70 · Close $78.85 · Volume 1,594,167
  56. Aug 6, 2026 ET · Open $78.94 · High $81.77 · Low $78.75 · Close $81.37 · Volume 2,523,490
  57. Aug 7, 2026 ET · Open $81.23 · High $81.50 · Low $75.87 · Close $76.76 · Volume 3,604,464
  58. Aug 10, 2026 ET · Open $76.09 · High $77.89 · Low $75.67 · Close $77.49 · Volume 2,270,664
  59. Aug 11, 2026 ET · Open $78.65 · High $78.95 · Low $76.30 · Close $76.45 · Volume 1,270,141
  60. Aug 12, 2026 ET · Open $76.71 · High $77.71 · Low $75.34 · Close $75.64 · Volume 2,105,583
  61. Aug 13, 2026 ET · Open $76.80 · High $76.81 · Low $73.40 · Close $73.45 · Volume 1,771,363
  62. Aug 14, 2026 ET · Open $72.70 · High $74.26 · Low $72.12 · Close $74.13 · Volume 1,756,968
  63. Aug 17, 2026 ET · Open $73.90 · High $75.92 · Low $73.46 · Close $75.87 · Volume 1,492,023
  64. Aug 18, 2026 ET · Open $75.57 · High $76.81 · Low $74.76 · Close $76.10 · Volume 1,653,100
  65. Aug 19, 2026 ET · Open $77.23 · High $77.88 · Low $76.17 · Close $77.74 · Volume 1,505,964
  66. Aug 20, 2026 ET · Open $77.36 · High $77.62 · Low $76.14 · Close $77.18 · Volume 1,651,714
  67. Aug 21, 2026 ET · Open $77.30 · High $77.70 · Low $76.65 · Close $76.84 · Volume 1,521,261
  68. Aug 24, 2026 ET · Open $77.20 · High $77.99 · Low $75.65 · Close $77.09 · Volume 1,212,285
  69. Aug 25, 2026 ET · Open $77.93 · High $78.72 · Low $77.21 · Close $77.46 · Volume 1,260,832
  70. Aug 26, 2026 ET · Open $77.91 · High $79.88 · Low $76.70 · Close $79.20 · Volume 1,236,620
  71. Aug 27, 2026 ET · Open $78.84 · High $79.13 · Low $77.84 · Close $77.90 · Volume 1,109,945
  72. Aug 28, 2026 ET · Open $73.88 · High $74.42 · Low $71.66 · Close $72.09 · Volume 4,361,525
  73. Aug 31, 2026 ET · Open $71.54 · High $71.79 · Low $69.31 · Close $70.91 · Volume 3,078,140
  74. Sep 1, 2026 ET · Open $69.85 · High $72.46 · Low $69.83 · Close $71.40 · Volume 1,899,653
  75. Sep 2, 2026 ET · Open $71.90 · High $73.70 · Low $70.42 · Close $71.93 · Volume 1,605,679
  76. Sep 3, 2026 ET · Open $73.55 · High $74.23 · Low $71.41 · Close $73.95 · Volume 1,589,734
  77. Sep 4, 2026 ET · Open $73.04 · High $74.01 · Low $72.26 · Close $72.72 · Volume 1,140,923
  78. Sep 8, 2026 ET · Open $72.39 · High $76.81 · Low $72.39 · Close $75.35 · Volume 1,921,008
  79. Sep 9, 2026 ET · Open $74.31 · High $74.89 · Low $73.52 · Close $74.11 · Volume 1,424,847
  80. Sep 10, 2026 ET · Open $73.23 · High $75.10 · Low $73.13 · Close $73.62 · Volume 1,444,873
  81. Sep 11, 2026 ET · Open $74.66 · High $75.98 · Low $73.50 · Close $73.77 · Volume 1,721,518
  82. Sep 14, 2026 ET · Open $73.51 · High $74.65 · Low $72.34 · Close $72.45 · Volume 1,533,560
  83. Sep 15, 2026 ET · Open $72.13 · High $72.19 · Low $68.55 · Close $69.31 · Volume 2,576,731
  84. Sep 16, 2026 ET · Open $69.52 · High $70.68 · Low $68.67 · Close $69.39 · Volume 2,211,795
  85. Sep 17, 2026 ET · Open $70.64 · High $71.05 · Low $68.92 · Close $69.92 · Volume 1,398,170
  86. Sep 18, 2026 ET · Open $70.18 · High $70.18 · Low $68.15 · Close $68.78 · Volume 4,872,972
  87. Sep 21, 2026 ET · Open $69.30 · High $69.50 · Low $67.35 · Close $67.56 · Volume 1,603,484
  88. Sep 22, 2026 ET · Open $68.07 · High $69.56 · Low $67.48 · Close $67.59 · Volume 2,388,591
  89. Sep 23, 2026 ET · Open $67.02 · High $67.39 · Low $64.73 · Close $65.81 · Volume 2,050,950
  90. Sep 24, 2026 ET · Open $65.37 · High $66.47 · Low $64.89 · Close $65.66 · Volume 1,836,856
  91. Sep 25, 2026 ET · Open $65.66 · High $65.95 · Low $64.44 · Close $64.66 · Volume 1,599,221
  92. Sep 28, 2026 ET · Open $64.58 · High $66.41 · Low $64.25 · Close $66.16 · Volume 2,551,193
  93. Sep 29, 2026 ET · Open $65.91 · High $66.52 · Low $64.38 · Close $65.64 · Volume 2,401,772
  94. Sep 30, 2026 ET · Open $65.90 · High $66.92 · Low $65.25 · Close $65.91 · Volume 2,977,682
  95. Oct 1, 2026 ET · Open $65.73 · High $67.27 · Low $65.30 · Close $65.62 · Volume 1,724,383
  96. Oct 2, 2026 ET · Open $66.45 · High $66.91 · Low $64.49 · Close $65.60 · Volume 2,649,872
  97. Oct 5, 2026 ET · Open $65.60 · High $65.76 · Low $62.19 · Close $62.70 · Volume 3,234,412
  98. Oct 6, 2026 ET · Open $62.20 · High $62.53 · Low $60.68 · Close $61.35 · Volume 3,228,904
  99. Oct 7, 2026 ET · Open $61.09 · High $62.05 · Low $60.15 · Close $61.12 · Volume 2,395,559
  100. Oct 8, 2026 ET · Open $60.31 · High $62.79 · Low $59.79 · Close $62.01 · Volume 2,594,639
  101. Oct 9, 2026 ET · Open $61.87 · High $63.03 · Low $61.59 · Close $62.91 · Volume 1,118,471
  102. Oct 12, 2026 ET · Open $62.48 · High $63.50 · Low $62.13 · Close $62.79 · Volume 1,254,061
  103. Oct 13, 2026 ET · Open $62.32 · High $63.05 · Low $61.50 · Close $61.62 · Volume 1,935,973
  104. Oct 14, 2026 ET · Open $61.62 · High $64.01 · Low $60.99 · Close $63.43 · Volume 2,095,777
  105. Oct 15, 2026 ET · Open $64.81 · High $65.57 · Low $63.81 · Close $63.92 · Volume 1,665,168
  106. Oct 16, 2026 ET · Open $63.90 · High $63.90 · Low $61.69 · Close $61.95 · Volume 1,204,683
  107. Oct 19, 2026 ET · Open $62.06 · High $63.61 · Low $61.84 · Close $62.65 · Volume 1,912,775
  108. Oct 20, 2026 ET · Open $63.13 · High $64.76 · Low $62.88 · Close $63.95 · Volume 1,050,368
  109. Oct 21, 2026 ET · Open $64.30 · High $64.78 · Low $62.46 · Close $62.86 · Volume 1,080,574
  110. Oct 22, 2026 ET · Open $63.01 · High $64.07 · Low $61.94 · Close $62.33 · Volume 2,061,246
  111. Oct 23, 2026 ET · Open $62.01 · High $62.44 · Low $60.89 · Close $61.23 · Volume 985,632
  112. Oct 26, 2026 ET · Open $61.45 · High $61.89 · Low $60.48 · Close $60.73 · Volume 783,238
  113. Oct 27, 2026 ET · Open $60.68 · High $61.83 · Low $60.47 · Close $61.52 · Volume 1,148,268
  114. Oct 28, 2026 ET · Open $60.86 · High $61.39 · Low $60.15 · Close $61.28 · Volume 1,274,169
  115. Oct 29, 2026 ET · Open $62.08 · High $63.95 · Low $61.54 · Close $63.31 · Volume 1,425,390
  116. Oct 30, 2026 ET · Open $63.44 · High $64.50 · Low $62.55 · Close $62.99 · Volume 1,257,213
  117. Nov 2, 2026 ET · Open $63.40 · High $64.00 · Low $61.97 · Close $62.03 · Volume 1,561,073
  118. Nov 3, 2026 ET · Open $62.74 · High $64.37 · Low $62.05 · Close $62.31 · Volume 1,699,316
  119. Nov 4, 2026 ET · Open $64.06 · High $64.96 · Low $60.98 · Close $63.60 · Volume 2,917,187
  120. Nov 5, 2026 ET · Open $60.04 · High $60.84 · Low $54.16 · Close $55.55 · Volume 6,776,024
  121. Nov 6, 2026 ET · Open $55.70 · High $56.51 · Low $53.55 · Close $53.69 · Volume 2,562,876
  122. Nov 9, 2026 ET · Open $54.38 · High $55.85 · Low $53.58 · Close $55.14 · Volume 3,119,553
  123. Nov 10, 2026 ET · Open $54.67 · High $57.21 · Low $54.12 · Close $56.18 · Volume 2,357,598
  124. Nov 11, 2026 ET · Open $56.40 · High $59.08 · Low $55.74 · Close $58.53 · Volume 2,811,699
  125. Nov 12, 2026 ET · Open $58.30 · High $58.58 · Low $55.67 · Close $56.16 · Volume 2,009,165
  126. Nov 13, 2026 ET · Open $56.55 · High $56.66 · Low $55.15 · Close $56.13 · Volume 1,014,590
  127. Nov 16, 2026 ET · Open $55.29 · High $55.62 · Low $52.68 · Close $53.17 · Volume 1,756,350
  128. Nov 17, 2026 ET · Open $52.68 · High $52.98 · Low $51.37 · Close $51.65 · Volume 2,712,185
  129. Nov 18, 2026 ET · Open $51.48 · High $52.84 · Low $51.00 · Close $51.32 · Volume 1,580,502

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of Nov 18, 2026, 8:47 PM ET

Initial 6M price range summary
Range6M
First close$75.18
Last close$51.32
High$88.31
Low$51.00
Volume262,102,039
Open
—Historical · Nov 18, 2026
Previous close
—Historical · Nov 18, 2026
Day range
—Historical · Nov 18, 2026
52-week range—
Volume
—Historical · Nov 18, 2026
Average volume (30 calendar days)—
Market cap—
P/E (TTM)—
Forward P/E—
EPS (TTM)—
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)—

Price history

CYTK · NASDAQ · USD

Split-adjusted · volume in shares

Price history unavailable

Notable price movement

Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.

  1. $53.17−5.27%

    Trading volume was 0.9 times the 30-day average, with 1.76M shares traded.

  2. $55.55−12.66%

    Trading volume was 4.1 times the 30-day average, with 6.78M shares traded.

  3. $63.31+3.31%

    Trading volume was 0.8 times the 30-day average, with 1.43M shares traded.

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18
Squeeze45Watch—
How the scores work →

How CYTK compares with its industry

Against 592 other US-listed Biotechnology stocks

Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%

Strongest points

  1. Latest-quarter year-over-year sales growth was 2356.5%, higher than 98% of 592 peers.Peer median 0.0% · As of Nov 17, 2026

Points of caution

  1. Trailing-year return on equity was -572.1%, with only 6% of 554 peers reporting a lower value.Peer median −67.8% · As of Nov 17, 2026
  2. Trailing-year net margin was 0%, with only 19% of 583 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026

Valuation

Higher multiples than peers

  • Price/sales69.02×13.85×

    Higher than 75% of 407 peers

  • Forward P/E117.65×14.84×

    Not ranked: only 193 of 592 peers report it

  • Price/book60.31×2.57×
    Highest 10%

    Higher than 96% of 551 peers

Profitability

Profitability metrics are lower than most peers.

  • Gross margin—78.4%

    Not ranked: only 247 of 592 peers report it

  • Operating margin—0.0%

    Not ranked: only 443 of 592 peers report it

  • Net margin0.0%0.0%

    Higher than 19% of 583 peers

  • Return on equity−572.2%−67.8%
    Bottom 10% of peers

    Higher than 6% of 554 peers

Growth

Growth metrics are higher than most peers.

  • Quarterly sales growth, year over year2,356.5%0.0%
    Top 10% of peers

    Higher than 98% of 592 peers

  • 5-year sales growth rate9.5%11.6%

    Not ranked: only 139 of 592 peers report it

Balance sheet

Balance sheet metrics are lower than most peers.

  • Current ratio3.365.03

    Higher than 36% of 498 peers

  • Debt/equity (total borrowings)—0.23

    Not ranked: only 117 of 592 peers report it

Momentum

Returns are mixed versus peers.

  • 1-year return−23.3%−28.4%

    Higher than 54% of 522 peers

  • 6-month return−34.8%−26.6%

    Higher than 41% of 545 peers

  • 3-month return−33.5%−29.4%

    Higher than 45% of 558 peers

Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 13, 2026

Upcoming events

— · Upcoming events not available

Analyst consensus

Buy

0Strong Buy
17Buy
0Neutral
0Sell
0Strong Sell

Based on 17 active firms as of Nov 19, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$84.00
Average$108.44
High$140.00

As of Nov 19, 2026 across 16 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Earnings history

EPS, last 8 quarters
EstimateBeatMissMatch
Fiscal periodEst.ActualResult
Q3 2026−$1.40−$1.37—
Q2 2026—−$1.50—
Q1 2026−$1.65−$1.67—
Annual 2025−$1.56−$6.54—
Q3 2025—−$2.55—
Q2 2025—−$1.12—
Q1 2025—−$1.36—
Annual 2024−$1.17−$5.26—

Smart-money activity

In the last 60 days: 15 insider sales and 0 purchases. Last quarter: 0 new 13F positions. Congressional trades in 90 days: 1.

DateTypeWhoActionAmountSource
Insider sellBlum Robert ISell$11.0KForm 4
Insider sellBlum Robert ISell$120.2KForm 4
Insider sellBlum Robert ISell$270.2KForm 4
Insider sellMalik Fady IbrahamSell$10.5KForm 4
Insider sellMalik Fady IbrahamSell$170.7KForm 4
Insider sellHessekiel JeffreySell$794.9KForm 4
Insider sellPARSHALL B LYNNESell$141.2KForm 4
Insider sellPARSHALL B LYNNESell$132.4KForm 4
Insider sellMalik Fady IbrahamSell$220.3KForm 4
Insider sellBlum Robert ISell$471.1KForm 4
All smart-money activity →

News and press releases

All CYTK news →

Company profile

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a

CEO
Mr. Robert I. Blum
Headquarters
South San Francisco, CA, United States
Employees
673
IPO date
Apr 29, 2004
Sector
Healthcare
Industry
Biotechnology

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.